NANOMEDICINE OFFERS PHARMA COMPANIES NEW HORIZONS FOR DRUG DEVELOPMENT
July 1st, 2011
BY MARK ROWE
FOR the pharmaceutical industry, nanotechnology has until recently been a horizon issue. The public focus has lain elsewhere - on novel foods and super-efficient electronic devices. But nanomedicine was brought to prominence in July with the news that a patient received a new windpipe grown from a nanomaterial-based tissue scaffold, seeded with the patient's own stem cells.
Scientists at Karolinska University hospital in Sweden used an organ wholly grown in a laboratory on a nanocomposite polymer frame. The polymer material had a nanostructure ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.